| Home |
| About ISG |
| About influenza |
| Vaccinations |
| Treatments |
| Influenza resources |
| Links |
| Media |
| News |
| Sponsors |
 |
We comply with the HONcode standard for trustworthy health information: verify here. |
| Tamiflu to stay on prescription |
|
|
August 2008The National Drugs and Poisons Committee announced this month its decision to maintain the current prescription only (S4) scheduling of oseltamivir, a treatment for seasonal influenza. A submission made earlier this year to the Committee regarding the rescheduling of oseltamivir to a pharmacist only (S3) medication instigated the Committee's review. The Committee concluded at its June meeting that a rescheduling was unnecessary as state governments were putting in place legislation and regulation to extend access to the drug during an influenza epidemic. The decision to keep oseltamivir on prescription rather than down-schedule it to S3 was made despite the majority, ten out of fourteen submissions received, being in favour of a down-scheduling. Content Update (Wednesday, 3rd September 2008) |